From Raw Data to Actionable Insights
Current: Raw + Ancestry
Re-analyzed 23andMe data with SOMOS proprietary algorithms
Value: $500
Next: + Health Records
Medical history, family data, lifestyle factors
Potential: $2,000
Future: + AI Analysis
Predictive models, drug response, disease risk
Potential: $10,000+
Key Innovation: Each enhancement adds value while maintaining patient ownership and control through Story Protocol's programmable IP licensing.